Immunogenicity induced by the use of alternative vaccine platforms to deal with vaccine shortages in a low- to middle-income country: Results of two randomized clinical trials

Author:

Macchia AlejandroORCID,Ferrante Daniel,Bouzas María Belén,Angeleri Patricia,Biscayart CristiánORCID,Geffner Jorge,Mammana Lilia,Zapiola Inés,López Eduardo Luis,Gentile Angela,Varese AugustoORCID,Mazzitelli Ignacio,García Facundo Di Diego,Sharff Deborah,Lucconi Verónica,Sujansky Paula,Mariani Javier,de Quirós Fernán González Bernaldo

Publisher

Elsevier BV

Reference21 articles.

1. Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia;Logunov;Lancet,2021

2. Mounting evidence suggests Sputnik COVID vaccine is safe and effective;Nogrady;Nature,2021

3. Evaluation of a COVID-19 vaccine campaign and SARS-CoV-2 infection and mortality Among Adults Older than 60 years in a middle income country using Sputnik V, AstraZeneca and SinoPharm vaccines: an observational study;Macchia;JAMA Open,2021

4. Covid: stalled Russian vaccines cause global anger. available at https://www.bbc.com/news/world-europe-58003893. Accessed 9 May 2021

5. Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial;Borobia;Lancet,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3